Want to join the conversation?
$AVGO 2Q15 10-Q: As of May 3, 2015, total assets were $10.53Bil vs. $3.67Bil as of May 4, 2014. Liabilities were $6.47Bil vs. $0.52Bil as of May 4, 2014. Long-term debt was $3.93Bil vs. $4.53Bil as of Nov. 2, 2014. Cash and cash equivalents were $2,508MM vs. $1,278MM as of May 4, 2014. Dividends declared per share were $0.38 vs. $0.27 in 2Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.